Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1R21 Divergent Transcript (PPP1R21-DT) is a human gene encoding a long non-coding RNA (lncRNA) and is classified as a divergent transcript. Unlike protein-coding genes, PPP1R21-DT does not produce a protein and is primarily characterized as an RNA gene. Its canonical gene symbol is PPP1R21-DT, and it is affiliated with the lncRNA class. The physiological or pathological role of PPP1R21-DT has not been established, and it is not considered a candidate for therapeutic targeting or biomarker development in current scientific literature[5][6]. Important clarification: PPP1R21-DT should not be confused with PPP1R21 (Protein Phosphatase 1 Regulatory Subunit 21), which is a protein-coding gene involved in endosomal transport and neurodevelopmental disorders[1][2][3][4]. PPP1R21-DT is a distinct entity and does not function as a receptor, enzyme, or conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PPP1R21 Divergent Transcript (PPP1R21-DT).